Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
Primary Purpose
Late Postvitrectomy Diabetic Hemorrhage.
Status
Completed
Phase
Not Applicable
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Cryotherapy
Sponsored by

About this trial
This is an interventional prevention trial for Late Postvitrectomy Diabetic Hemorrhage. focused on measuring Rebleeding, Diabetic vitreous hemorrhage, Cryotherapy
Eligibility Criteria
Inclusion Criteria: Diabetic retinopathy cases undergoing vitrectomy Exclusion Criteria: History of deep vitrectomy or cataract surgery Renal failure Silicone oil injection during surgery Early rebleeding History of antithrombotic drugs usage
Sites / Locations
- Ophthalmic Research Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Cryotherapy
Outcomes
Primary Outcome Measures
Prevention of late vitreous hemorrhage in postvitrectomized diabetic eyes
Secondary Outcome Measures
Incidence of late vitreous hemorrhage in the cryo group.
Incidence of late vitreous hemorrhage in the control group.
Comparing incidence of late vitreous hemorrhage in both groups.
Full Information
NCT ID
NCT00370409
First Posted
August 30, 2006
Last Updated
July 31, 2008
Sponsor
Shahid Beheshti University of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT00370409
Brief Title
Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
Study Type
Interventional
2. Study Status
Record Verification Date
July 2008
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
June 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Shahid Beheshti University of Medical Sciences
4. Oversight
5. Study Description
Brief Summary
Late vitreous hemorrhage in postvitrectomized diabetic eyes may be due to fibrovascular tuft formation in sclerotomy sites. Cryotherapy of sclerotomy sites may prevent bleeding by regressing the fibrovascular tuft. This study will detect the safety and efficacy of cryotherapy of sclerotomy sites for prevention of late vitreous hemorrhage in vitrectomized diabetic eyes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Late Postvitrectomy Diabetic Hemorrhage.
Keywords
Rebleeding, Diabetic vitreous hemorrhage, Cryotherapy
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
112 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Cryotherapy
Arm Title
2
Arm Type
Placebo Comparator
Intervention Type
Procedure
Intervention Name(s)
Cryotherapy
Intervention Description
Cryotherapy of both sides of sclerotomy sites was done for 6 seconds after complition of operation.
Primary Outcome Measure Information:
Title
Prevention of late vitreous hemorrhage in postvitrectomized diabetic eyes
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Incidence of late vitreous hemorrhage in the cryo group.
Time Frame
6 months
Title
Incidence of late vitreous hemorrhage in the control group.
Time Frame
6 months
Title
Comparing incidence of late vitreous hemorrhage in both groups.
Time Frame
6 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diabetic retinopathy cases undergoing vitrectomy
Exclusion Criteria:
History of deep vitrectomy or cataract surgery
Renal failure
Silicone oil injection during surgery
Early rebleeding
History of antithrombotic drugs usage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Morteza Entezari, MD
Organizational Affiliation
Ophthalmic Research Center of Shaheed Beheshti Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ophthalmic Research Center
City
Tehran
ZIP/Postal Code
16666
Country
Iran, Islamic Republic of
12. IPD Sharing Statement
Learn more about this trial
Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
We'll reach out to this number within 24 hrs